Statin-fibrate combinations in patients with combined hyperlipedemia

Atherosclerosis. 2001 Mar;155(1):263-4. doi: 10.1016/s0021-9150(00)00726-7.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Clofibric Acid / administration & dosage
  • Clofibric Acid / analogs & derivatives
  • Coronary Disease / mortality
  • Drug Therapy, Combination
  • Fibric Acids
  • Follow-Up Studies
  • Gemfibrozil / administration & dosage*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Hyperlipidemia, Familial Combined / blood
  • Hyperlipidemia, Familial Combined / complications
  • Hyperlipidemia, Familial Combined / drug therapy*
  • Hyperlipoproteinemia Type V / drug therapy
  • Hypolipidemic Agents / administration & dosage*
  • Myocardial Infarction / complications
  • Pravastatin / administration & dosage
  • Simvastatin / administration & dosage*
  • Stroke / mortality

Substances

  • Fibric Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Clofibric Acid
  • Simvastatin
  • ciprofibrate
  • Pravastatin
  • Gemfibrozil